BSE Live
Apr 10, 16:01Prev. Close
157.75
Open Price
156.15
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 27, 11:22Prev. Close
-
Open Price
-
Bid Price (Qty.)
- (0)
Offer Price (Qty.)
- (0)
| Balance Sheet of Makers Laboratories (in Rs. Cr.) | Mar 15 | Mar 14 | Mar 13 | Mar 12 | Mar 11 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 4.92 | 4.92 | 4.92 | 4.92 | 4.92 | |
| Total Share Capital | 4.92 | 4.92 | 4.92 | 4.92 | 4.92 | |
| Reserves and Surplus | 19.71 | 17.99 | 17.39 | 14.95 | 15.52 | |
| Total Reserves and Surplus | 19.71 | 17.99 | 17.39 | 14.95 | 15.52 | |
| Total Shareholders Funds | 24.63 | 22.90 | 22.31 | 19.87 | 20.44 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 0.00 | 0.00 | 0.00 | 0.46 | 0.92 | |
| Deferred Tax Liabilities [Net] | 0.65 | 0.75 | 0.74 | 0.51 | 0.60 | |
| Other Long Term Liabilities | 3.77 | 4.00 | 1.20 | 1.21 | 1.00 | |
| Long Term Provisions | 0.18 | 0.13 | 0.14 | 0.12 | 0.08 | |
| Total Non-Current Liabilities | 4.61 | 4.88 | 2.07 | 2.30 | 2.59 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 0.80 | 2.12 | 4.40 | 7.56 | 10.05 | |
| Trade Payables | 7.55 | 10.46 | 9.25 | 7.40 | 3.59 | |
| Other Current Liabilities | 0.38 | 0.37 | 0.40 | 0.77 | 0.91 | |
| Short Term Provisions | 1.14 | 0.28 | 0.31 | 0.19 | 0.78 | |
| Total Current Liabilities | 9.86 | 13.23 | 14.37 | 15.92 | 15.33 | |
| Total Capital And Liabilities | 39.10 | 41.02 | 38.75 | 38.09 | 38.36 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 11.40 | 11.84 | 12.21 | 12.37 | 12.11 | |
| Intangible Assets | 0.07 | 0.10 | 0.05 | 0.01 | 0.01 | |
| Capital Work-In-Progress | 2.71 | 1.92 | 0.01 | 0.00 | 0.00 | |
| Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Fixed Assets | 14.18 | 13.85 | 12.27 | 12.38 | 12.12 | |
| Non-Current Investments | 2.35 | 2.50 | 4.04 | 4.60 | 4.60 | |
| Deferred Tax Assets [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long Term Loans And Advances | 0.31 | 0.82 | 0.94 | 2.11 | 4.70 | |
| Other Non-Current Assets | 0.41 | 0.25 | 0.01 | 0.00 | 0.00 | |
| Total Non-Current Assets | 17.25 | 17.41 | 17.25 | 19.09 | 21.42 | |
| CURRENT ASSETS | ||||||
| Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Inventories | 9.25 | 9.92 | 10.23 | 9.62 | 7.89 | |
| Trade Receivables | 11.84 | 12.53 | 9.88 | 7.36 | 7.11 | |
| Cash And Cash Equivalents | 0.07 | 0.16 | 0.43 | 0.46 | 0.78 | |
| Short Term Loans And Advances | 0.43 | 0.57 | 0.96 | 1.51 | 1.12 | |
| OtherCurrentAssets | 0.26 | 0.43 | 0.00 | 0.05 | 0.04 | |
| Total Current Assets | 21.85 | 23.61 | 21.50 | 19.00 | 16.94 | |
| Total Assets | 39.10 | 41.02 | 38.75 | 38.09 | 38.36 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 0.42 | 0.02 | 0.02 | 1.64 | 1.79 | |
| CIF VALUE OF IMPORTS | ||||||
| Raw Materials | 0.00 | 0.00 | 0.99 | 0.77 | 0.00 | |
| Stores, Spares And Loose Tools | 0.55 | 0.80 | 0.00 | 0.00 | 0.00 | |
| Trade/Other Goods | 0.55 | 0.80 | 0.00 | 0.00 | 0.00 | |
| Capital Goods | 0.06 | 0.14 | 0.16 | 0.12 | 0.19 | |
| EXPENDITURE IN FOREIGN EXCHANGE | ||||||
| Expenditure In Foreign Currency | 0.04 | 0.03 | 0.03 | 0.01 | 0.00 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
| Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
| EARNINGS IN FOREIGN EXCHANGE | ||||||
| FOB Value Of Goods | -- | -- | -- | -- | -- | |
| Other Earnings | -- | -- | -- | -- | -- | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | -- | -- | -- | -- | -- | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | 6.48 | 8.72 | 5.53 | 3.71 | 3.44 | |
| Non-Current Investments Unquoted Book Value | 1.34 | 1.34 | 2.84 | 3.19 | 3.19 | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Current Investments Unquoted Book Value | -- | -- | -- | -- | -- |
20.02.2026
Makers Labs Consolidated December 2025 Net Sales at Rs 35.67 crore, up 28.81% Y-o-Y
19.02.2026
Makers Labs Standalone December 2025 Net Sales at Rs 12.70 crore, up 34.43% Y-o-Y
14.11.2025
Makers Labs Consolidated September 2025 Net Sales at Rs 34.17 crore, up 15.58% Y-o-Y
12.11.2025
Makers Labs Standalone September 2025 Net Sales at Rs 12.64 crore, up 9.89% Y-o-Y
20.02.2026
Makers Labs Consolidated December 2025 Net Sales at Rs 35.67 crore, up 28.81% Y-o-Y
19.02.2026
Makers Labs Standalone December 2025 Net Sales at Rs 12.70 crore, up 34.43% Y-o-Y
14.11.2025
Makers Labs Consolidated September 2025 Net Sales at Rs 34.17 crore, up 15.58% Y-o-Y
12.11.2025
Makers Labs Standalone September 2025 Net Sales at Rs 12.64 crore, up 9.89% Y-o-Y
10.04.2026
09.04.2026
08.04.2026
Indian CDMOs face tariff exposure via patented drug supply chains
08.04.2026
21.01.2026
Dr Reddy's posts smaller-than-expected Q3 profit fall on domestic boost
12.11.2025
07.11.2025
24.10.2025
Dr Reddy's Q2 Results: Net profit rises 7% to Rs 1,347 crore, misses estimates
17.07.2025
Sun Pharma Q1 PAT seen up 8.4% YoY to Rs 3,132.7 cr: ICICI Securities
17.07.2025
Biocon Q1 PAT may dip 72% YoY to Rs 91.1 cr: ICICI Securities
17.07.2025
Cipla Q1 PAT seen up 2% YoY to Rs 1,246.7 cr: ICICI Securities
29.01.2025
Sun Pharma Q3 Preview: Double-digit India, US sales to power mid-teen profit growth